{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["28(1)"],"submitter":["Zampieri FG"],"pubmed_abstract":["<h4>Background</h4>Exploring clinical trial data using alternative methods may enhance original study's findings and provide new insights. The SOAP II trial has been published more than 10 years ago; but there is still some speculation that some patients may benefit from dopamine administration for shock management. We aimed to reanalyse the trial under different approaches and evaluate for heterogeneity in treatment effect (HTE).<h4>Methods</h4>All patients enrolled in SOAP II were eligible for reanalysis. We used a variety of methods including the win-ratio (WR), a Bayesian reanalysis stratified according to shock type, and both a risk-based and effect-based explorations for HTE. The methods were applied to different endpoints, including a hierarchy of death, new use of renal-replacement"],"journal":["Critical care (London, England)"],"pagination":["299"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11385121"],"repository":["biostudies-literature"],"pubmed_title":["Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II."],"pmcid":["PMC11385121"],"pubmed_authors":["Devriendt J","De Bels D","Aldecoa C","Melot C","VanCutsem M","Van Nuffelen M","Rico J","Bagshaw SM","Njimi H","Biston P","Brasseur A","Brimioulle S","Gottignies P","Zampieri FG","SOAP II Investigators","Roman A","Anane S","Defrance P","Kitzberger R","Madl C","DeBacker D","Chochrad D","Holzinger U","Vincent JL","Gomez Herreras JI"],"additional_accession":[]},"is_claimable":false,"name":"Exploration of different statistical approaches in the comparison of dopamine and norepinephrine in the treatment of shock: SOAP II.","description":"<h4>Background</h4>Exploring clinical trial data using alternative methods may enhance original study's findings and provide new insights. The SOAP II trial has been published more than 10 years ago; but there is still some speculation that some patients may benefit from dopamine administration for shock management. We aimed to reanalyse the trial under different approaches and evaluate for heterogeneity in treatment effect (HTE).<h4>Methods</h4>All patients enrolled in SOAP II were eligible for reanalysis. We used a variety of methods including the win-ratio (WR), a Bayesian reanalysis stratified according to shock type, and both a risk-based and effect-based explorations for HTE. The methods were applied to different endpoints, including a hierarchy of death, new use of renal-replacement","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Sep","modification":"2026-05-29T22:30:26.387Z","creation":"2025-04-20T00:44:55.598Z"},"accession":"S-EPMC11385121","cross_references":{"pubmed":["39256813"],"doi":["10.1186/s13054-024-05016-9"]}}